Literature DB >> 11910470

Recurrent inguinal hernia: disease of the collagen matrix?

Hong Zheng1, Zhongyi Si, Reiner Kasperk, Rhanjit S Bhardwaj, Volker Schumpelick, Uwe Klinge, Bernd Klosterhalfen.   

Abstract

The aim of this study was to investigate the collagen matrix in recurrent inguinal hernias. Total ribonucleic acid (RNA) was extracted from skin fibroblasts of three groups (control group I = healthy skin; control group II = plain skin scar; recurrent inguinal hernia group = skin of recurrent inguinal hernias; each n = 5). Reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis were used to investigate the expression of procollagen type I/- III, MMP-1, and MMP-13 mRNAs. Both ratios of procollagen types I to III mRNAs and collagen types I to III were apparently decreased in the recurrent hernia group compared to those of both control groups (p < 0.01). Significant differences were caused by the increase of both procollagen type III mRNA and collagen type III protein synthesis. A concomitant increase of MMP-1 and MMP-13 mRNAs and proteins was also observed in the recurrent hernia group and showed significant differences compared to those of both control groups I and II, respectively (p < 0.01). In conclusion, the decreased ratio of collagen types I to III seems not only to be the result of a relative increase in the levels of type III procollagen mRNA but also may be the result of an increase of MMP-1 and MMP-13. The data of the present study strongly suggest recurrent inguinal hernias to be a disease of the collagen matrix and result in a clearer understanding of the underlying pathophysiology and may support specific therapeutic strategies in hernia surgery (e.g., surgical meshes).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910470     DOI: 10.1007/s00268-001-0239-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  50 in total

Review 1.  Causes of recurrences after open inguinal herniorrhaphy.

Authors:  D Ashrafi; M Siddaiah-Subramanya; B Memon; M A Memon
Journal:  Hernia       Date:  2018-12-05       Impact factor: 4.739

2.  Herniosis: a biological approach.

Authors:  U Klinge; K Junge; P R Mertens
Journal:  Hernia       Date:  2004-12       Impact factor: 4.739

Review 3.  Collagenase and surgical disease.

Authors:  Timothy R Donahue; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

4.  Dimensions of the myopectineal orifice: a human cadaver study.

Authors:  T Wolloscheck; M A Konerding
Journal:  Hernia       Date:  2009-09-11       Impact factor: 4.739

Review 5.  Biocompatibility of prosthetic meshes in abdominal surgery.

Authors:  Marcel Binnebösel; Klaus T von Trotha; Petra Lynen Jansen; Joachim Conze; Ulf P Neumann; Karsten Junge
Journal:  Semin Immunopathol       Date:  2011-01-12       Impact factor: 9.623

6.  Etiology of inguinal hernia: ultrastructure of rectus sheath revisited.

Authors:  W Szczesny; K Cerkaska; A Tretyn; S Dabrowiecki
Journal:  Hernia       Date:  2006-04-01       Impact factor: 4.739

7.  Differential regulation of MMP-2 in the gastrohepatic ligament of the gastroesophageal junction.

Authors:  Lora Melman; Phillip R Chisholm; John A Curci; Batool Arif; Richard Pierce; Eric D Jenkins; L Michael Brunt; Christopher Eagon; Margaret Frisella; Kathleen Miller; Brent D Matthews
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

8.  Causes of recurrence in laparoscopic inguinal hernia repair.

Authors:  Jan F Kukleta
Journal:  J Minim Access Surg       Date:  2006-09       Impact factor: 1.407

9.  Totally extraperitoneal repair of inguinal hernia: A case for bilateral repair.

Authors:  Pradeep K Chowbey; Murtaza Pithawala; Rajesh Khullar; Anil Sharma; Vandana Soni; Manish Baijal
Journal:  J Minim Access Surg       Date:  2006-09       Impact factor: 1.407

10.  Risk factors for early recurrence after inguinal hernia repair.

Authors:  Petra Lynen Jansen; Uwe Klinge; Marc Jansen; Karsten Junge
Journal:  BMC Surg       Date:  2009-12-09       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.